VAVALLO, ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 1.178
EU - Europa 244
AS - Asia 154
AF - Africa 2
OC - Oceania 1
Totale 1.579
Nazione #
US - Stati Uniti d'America 1.173
CN - Cina 98
SE - Svezia 78
IT - Italia 55
SG - Singapore 47
FI - Finlandia 23
UA - Ucraina 22
GB - Regno Unito 20
BE - Belgio 18
DE - Germania 17
CA - Canada 5
VN - Vietnam 4
FR - Francia 3
IE - Irlanda 3
IN - India 3
IR - Iran 2
AU - Australia 1
BG - Bulgaria 1
CH - Svizzera 1
DZ - Algeria 1
EG - Egitto 1
HU - Ungheria 1
MT - Malta 1
RO - Romania 1
Totale 1.579
Città #
Fairfield 181
Chandler 143
Woodbridge 103
Ashburn 97
Houston 82
Ann Arbor 77
Cambridge 63
Wilmington 62
Nyköping 61
Seattle 55
Bari 47
Beijing 43
Jacksonville 43
Singapore 35
New York 25
Roxbury 19
Brussels 18
Lawrence 18
Princeton 15
Nanjing 14
Des Moines 13
Inglewood 13
Boardman 11
Los Angeles 7
Brooklyn 6
Shenyang 6
Dearborn 5
Hebei 5
Helsinki 5
Nanchang 5
San Diego 5
San Mateo 5
Dong Ket 4
Jiaxing 4
Monmouth Junction 4
Toronto 4
Changsha 3
Dublin 3
Falls Church 3
Frankfurt am Main 3
Guangzhou 3
Munich 3
Tianjin 3
Washington 3
Ardabil 2
Augusta 2
Cardiff 2
Chicago 2
Gioia del Colle 2
Lecce 2
London 2
Modugno 2
Norwalk 2
Pune 2
Redwood City 2
Alexandria 1
Algiers 1
Baotou 1
Barletta 1
Budapest 1
Chongqing 1
Cormeilles-en-Parisis 1
Hefei 1
Hounslow 1
Iasi 1
Il-Madliena 1
Kilburn 1
Kunming 1
Leawood 1
Luoyang 1
Miami 1
New Bedfont 1
New Delhi 1
Ningbo 1
Ottawa 1
Paris 1
Quanzhou 1
Santa Clara 1
Sofia 1
Tappahannock 1
Zurich 1
Totale 1.375
Nome #
Serum sarcosine increases the accuracy of prostate cancer detection in patients with total serum PSA less than 4.0 ng/ml. 140
Metabolomic profile of glycolysis and the pentose phosphate pathway identifies the central role of glucose-6-phosphate dehydrogenase in clear cell-renal cell carcinoma. 136
Isolation and characterization of cancer stem cells in renal cell carcinoma. 130
Capillary hemangioma of the scrotum mimicking an epididymal tumor: case report. 123
Impact of donor-recipient gender on kidney graft and patient survival: short- and long-term outcomes. 102
Pre-existing Type 2 Diabetes Mellitus Is an Independent Risk Factor for Mortality and Progression in Patients With Renal Cell Carcinoma. 96
Allograft nephrectomy: what is the best surgical technique? 89
Spondin-2, a Secreted Extracellular Matrix Protein, Is a Novel Diagnostic Biomarker for Prostate Cancer. 87
Serum sarcosine is a risk factor for progression and survival in patients with metastatic castration-resistant prostate cancer. 85
Extended criteria donor kidney transplantation: comparative outcome analysis between single versus double kidney transplantation at 5 years 82
A challenging surgical approach to locally advanced primary urethral carcinoma: A case report and literature review 81
SERUM SARCOSINE INCREASES THE ACCURACY OF PROSTATE CANCER DETECTION IN LOW RANGE PSA 81
Emerging urinary markers of renal injury in obstructive nephropathy. 77
Lymph node staging in early prostatic carcinoma with radioguided sentinel node biopsy 77
Diagnostic and prognostic role of preoperative circulating CA 15-3, CA 125, and beta-2 microglobulin in renal cell carcinoma. 63
null 61
LAMININA 5 COME MARKER NELLA DIAGNOSI E NELLA PROGNOSI DEL CARCINOMA UROTELIALE DELLA VESCICA 49
RENAL CELL CARCINOMA: DOES TRANSCRIPTIONAL DEREGULATION OF ADULT RENAL STEM/PROGENITOR CELLS LEAD TO ONCOGENESIS? 44
SARS-CoV-2 Infection as a Determining Factor to the Precipitation of Ischemic Priapism in a Young Patient with Asymptomatic COVID-19 31
First Case of Paraphimosis as a Severe Complication of Monkeypox 15
Totale 1.649
Categoria #
all - tutte 7.258
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.258


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020286 0 0 0 0 44 26 43 40 46 40 30 17
2020/2021229 13 45 9 12 33 4 9 19 10 27 27 21
2021/2022170 5 16 10 7 6 9 13 14 6 15 34 35
2022/2023323 46 51 27 34 29 40 1 38 34 1 8 14
2023/2024116 9 21 5 7 11 40 11 1 0 6 0 5
2024/202579 10 6 25 26 12 0 0 0 0 0 0 0
Totale 1.649